Developments Opsens in first clinical use of OptoWire III after Health Canada approval Opsens (TSX:OPS; OTCQX:OPSSF) announced the world’s first clinical use of its OptoWire III at the Quebec Heart and Lung Institute, following Health Canada’s recent approval of the device. OptoWire III is a... November 7, 2019